Thyroid Surgery: When is active surveillance the right decision? with Allen S. Ho, MD
Part 1 of 2 of Session 132 from #ThyCa20: Thyroid Surgery: When is active surveillance the right decision? Reconciling divergent options on treatment with Allen S. Ho, MD, Surgeon. Allen S. Ho, MD, is a surgeon, director of the Head and Neck Cancer Program and Co-Director of the Thyroid Cancer Program at Cedars-Sinai Medical Center in Los Angeles, California. He is a graduate of UCLA School of Medicine, completed his residency at Stanford University School of Medicine and fellowships at the National Institutes of Health in Bethesda, Maryland, and Memorial Sloan Kettering Cancer Center. Dr. Ho’s research interests include cancer proteomics, HPV-positive oropharyngeal cancer pathogenesis, and thyroid cancer molecular assays. He is the author of numerous peer-reviewed publications.

142 Active surveillance of small newly diagnosed primary thyroid cancers and nodal recurrences

Patient decision-making in low-risk papillary thyroid cancer, including active surveillance. 231

Thyroid Surgery for Graves’ Disease

Lymphoma | Clinical Medicine

Active Surveillance for Papillary Thyroid Cancer: When Is It The Right Choice?

Doctors Miss This ALL THE TIME with Thyroid Expert Dr. Amie Hornaman

Preview of preliminary work done for next iteration of the ATA guidelines for differentiated TC. 321

Normocalcemic Hyperparathyroidism Facebook Live

An Integrative, Pathology-Centered Perspective on Anal, Oral and Oropharyngeal HPV in Women

Cancer or not? The truth about thyroid nodules | Dr. Chhaya Makhija & thyroid surgeon interview

Selumetinib Plus Adjuvant Radioactive Iodine with Dr. Alan Ho

You Cannot Heal Your THYROID If You Do These 10 Things Daily

Innovations in Pediatric HCM Care: The SCOUT-HCM Clinical Trial of Mavacamten

212 Drugs in development for RAI-refractory differentiated thyroid cancer. New Molecular Targets

Case Study: Hashimoto's with Anxiety, Fatigue, Brain Fog & REALLY high thyroid antibodies

Barriers to the Adoption of Active Surveillance with Dr. Susan Pitt

Thyroid Nodule and Thyroid Cancer | Pathology Review | Osmosis

Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer

Session 163 Medullary thyroid cancer: The spectrum of treatments.

